HW241045

· Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HW241045, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia Clinical Trial of HW241045 [Phase 1]